emerge.png
Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning
March 11, 2022 06:34 ET | Emergent BioSolutions
GAITHERSBURG, Md., March 11, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its Phase 1 study to evaluate the safety,...
InMed LOGO.jpg
InMed to Present at the 34th Annual Roth Conference
March 08, 2022 07:30 ET | InMed Pharmaceuticals Inc.
Vancouver, BC, March 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and...
logo_Codex_landscape_color_RGB (1).png
Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
March 03, 2022 08:03 ET | Codex DNA, Inc.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D...
LOGO.png
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers
March 02, 2022 08:37 ET | Hillstream BioPharma Inc.
HSB-1216’s active moiety in clinical pilot study produced a 71% response rate in TNBC and epithelial carcinomasHSB-1216 was recently granted Orphan Drug Designation to treat Uveal Melanoma by the...
(Maryland) Main Lab 2
Axis Research & Technologies Opens Fourth U.S. Location
March 01, 2022 08:00 ET | Axis Research & Technologies
IRVINE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and training, announced the...
Shineco New Logo.png
Shineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical Devices
February 17, 2022 09:00 ET | Shineco, Inc.
BEIJING, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech...
Kraig Biocraft Laboratories Delivers Dragon Silk to Spydasilk Enterprises
February 10, 2022 07:05 ET | Kraig Biocraft Laboratories
ANN ARBOR, Mich., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and...
AMFELTEC.jpg
Amfeltec Corporation Has Moved to Larger Facility Due to Growth
February 07, 2022 11:00 ET | AMFELTEC Corporation
STOUFFVILLE, Ontario, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Amfeltec Corporation announced today that it has completed its move into a new facility on the outskirts of the Greater Toronto Area (GTA) to...
Retooling Research & Development for a New Era
New Report Finds Corporate R&D Budgets Increasing Amidst Pandemic; Artificial Intelligence and Sustainability Are Key Areas of Focus
January 25, 2022 10:00 ET | Innovation Leader
BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- InnoLead has released a new research report, "Retooling R&D for a New Era," that explores emerging trends in R&D in Global 1000 companies. It finds...
virtusa_logo.png
Virtusa Named a Leader in Five Segments of Zinnov Zones Global ER&D 2021 Ratings
January 25, 2022 09:00 ET | Virtusa Corporation
SOUTHBOROUGH, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Virtusa Corporation announced today that it has been ranked a leader in five segments in the annual Zinnov Zones for Engineering R&D 2021...